Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation

Zoltan Szallasi, Mitchell F. Denning, Colin B. Smith, Andrzej A. Dlugosz, Stuart H. Yuspa, George Pettit, Peter M. Blumberg

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Bryostatin 1 and phorbol-12-myristate-13-acetate (PMA) are both potent activators of protein kinase C (PKC), although in primary mouse keratinocytes bryostatin 1 does not induce differentiation and blocks PMA-induced differentiation. We report here that in primary mouse keratinocytes PMA caused translocation of PKC-ε to the Triton X-100-soluble fraction with an approximately 2-order of magnitude higher potency, compared with translocation of PKC-α and PKC-δ. The kinetics of translocation were fastest for PKC-ε, slower for PKC-α, and slowest for PKC-δ. At 5-20 min bryostatin 1 showed potency similar to that of PMA for translocating PKC-α, higher potency for translocating PKC-δ, and lower potency for translocating PKC-ε. At a later time (6 hr), bryostatin 1 was 1-2 orders magnitude more potent than PMA for causing loss of PKC-α, -δ, and -ε from the soluble fraction. Bryostatin 1 was 40-fold more potent than PMA for down-regulating PKC-α and showed a biphasic dose-response curve for down-regulating PKC-δ. Bryostatin 1 at 0.1-1 nM down-regulated PKC-δ to a similar extent as did PMA. Bryostatin 1 at 100 nM to 1 μM, on the other hand, failed to induce down-regulation, and these high (100 nM to 1 μM) doses of bryostatin 1 showed noncompetitive inhibition of PKC-δ down-regulation by 1 μM PMA after coapplication. This protected portion of PKC-δ retained kinase activity. The dose-response curve for bryostatin 1 protection of PKC-δ from down- regulation by PMA correlated with bryostatin 1 inhibition of the effects of PMA on cornified envelope formation (a marker of differentiation) and epidermal growth factor binding. Although PKC-ε was readily translocated by both PMA and bryostatin 1, the PKC-ε originally associated with the particulate fraction showed no down-regulation by either of these agents. We hypothesize that differential regulation of PKC isozymes by PMA and bryostatin 1 may contribute to the different patterns of biological responses that they induce.

Original languageEnglish (US)
Pages (from-to)840-850
Number of pages11
JournalMolecular Pharmacology
Volume46
Issue number5
StatePublished - Nov 1994

Fingerprint

Phorbol Esters
Keratinocytes
Protein Kinase C
Down-Regulation
Acetates
bryostatin 1
phorbol-12-myristate
Differentiation Antigens
Octoxynol
Epidermal Growth Factor

ASJC Scopus subject areas

  • Pharmacology

Cite this

Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. / Szallasi, Zoltan; Denning, Mitchell F.; Smith, Colin B.; Dlugosz, Andrzej A.; Yuspa, Stuart H.; Pettit, George; Blumberg, Peter M.

In: Molecular Pharmacology, Vol. 46, No. 5, 11.1994, p. 840-850.

Research output: Contribution to journalArticle

Szallasi, Zoltan ; Denning, Mitchell F. ; Smith, Colin B. ; Dlugosz, Andrzej A. ; Yuspa, Stuart H. ; Pettit, George ; Blumberg, Peter M. / Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. In: Molecular Pharmacology. 1994 ; Vol. 46, No. 5. pp. 840-850.
@article{e2be957dfcf240d9a51088092ad817e4,
title = "Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation",
abstract = "Bryostatin 1 and phorbol-12-myristate-13-acetate (PMA) are both potent activators of protein kinase C (PKC), although in primary mouse keratinocytes bryostatin 1 does not induce differentiation and blocks PMA-induced differentiation. We report here that in primary mouse keratinocytes PMA caused translocation of PKC-ε to the Triton X-100-soluble fraction with an approximately 2-order of magnitude higher potency, compared with translocation of PKC-α and PKC-δ. The kinetics of translocation were fastest for PKC-ε, slower for PKC-α, and slowest for PKC-δ. At 5-20 min bryostatin 1 showed potency similar to that of PMA for translocating PKC-α, higher potency for translocating PKC-δ, and lower potency for translocating PKC-ε. At a later time (6 hr), bryostatin 1 was 1-2 orders magnitude more potent than PMA for causing loss of PKC-α, -δ, and -ε from the soluble fraction. Bryostatin 1 was 40-fold more potent than PMA for down-regulating PKC-α and showed a biphasic dose-response curve for down-regulating PKC-δ. Bryostatin 1 at 0.1-1 nM down-regulated PKC-δ to a similar extent as did PMA. Bryostatin 1 at 100 nM to 1 μM, on the other hand, failed to induce down-regulation, and these high (100 nM to 1 μM) doses of bryostatin 1 showed noncompetitive inhibition of PKC-δ down-regulation by 1 μM PMA after coapplication. This protected portion of PKC-δ retained kinase activity. The dose-response curve for bryostatin 1 protection of PKC-δ from down- regulation by PMA correlated with bryostatin 1 inhibition of the effects of PMA on cornified envelope formation (a marker of differentiation) and epidermal growth factor binding. Although PKC-ε was readily translocated by both PMA and bryostatin 1, the PKC-ε originally associated with the particulate fraction showed no down-regulation by either of these agents. We hypothesize that differential regulation of PKC isozymes by PMA and bryostatin 1 may contribute to the different patterns of biological responses that they induce.",
author = "Zoltan Szallasi and Denning, {Mitchell F.} and Smith, {Colin B.} and Dlugosz, {Andrzej A.} and Yuspa, {Stuart H.} and George Pettit and Blumberg, {Peter M.}",
year = "1994",
month = "11",
language = "English (US)",
volume = "46",
pages = "840--850",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

TY - JOUR

T1 - Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation

AU - Szallasi, Zoltan

AU - Denning, Mitchell F.

AU - Smith, Colin B.

AU - Dlugosz, Andrzej A.

AU - Yuspa, Stuart H.

AU - Pettit, George

AU - Blumberg, Peter M.

PY - 1994/11

Y1 - 1994/11

N2 - Bryostatin 1 and phorbol-12-myristate-13-acetate (PMA) are both potent activators of protein kinase C (PKC), although in primary mouse keratinocytes bryostatin 1 does not induce differentiation and blocks PMA-induced differentiation. We report here that in primary mouse keratinocytes PMA caused translocation of PKC-ε to the Triton X-100-soluble fraction with an approximately 2-order of magnitude higher potency, compared with translocation of PKC-α and PKC-δ. The kinetics of translocation were fastest for PKC-ε, slower for PKC-α, and slowest for PKC-δ. At 5-20 min bryostatin 1 showed potency similar to that of PMA for translocating PKC-α, higher potency for translocating PKC-δ, and lower potency for translocating PKC-ε. At a later time (6 hr), bryostatin 1 was 1-2 orders magnitude more potent than PMA for causing loss of PKC-α, -δ, and -ε from the soluble fraction. Bryostatin 1 was 40-fold more potent than PMA for down-regulating PKC-α and showed a biphasic dose-response curve for down-regulating PKC-δ. Bryostatin 1 at 0.1-1 nM down-regulated PKC-δ to a similar extent as did PMA. Bryostatin 1 at 100 nM to 1 μM, on the other hand, failed to induce down-regulation, and these high (100 nM to 1 μM) doses of bryostatin 1 showed noncompetitive inhibition of PKC-δ down-regulation by 1 μM PMA after coapplication. This protected portion of PKC-δ retained kinase activity. The dose-response curve for bryostatin 1 protection of PKC-δ from down- regulation by PMA correlated with bryostatin 1 inhibition of the effects of PMA on cornified envelope formation (a marker of differentiation) and epidermal growth factor binding. Although PKC-ε was readily translocated by both PMA and bryostatin 1, the PKC-ε originally associated with the particulate fraction showed no down-regulation by either of these agents. We hypothesize that differential regulation of PKC isozymes by PMA and bryostatin 1 may contribute to the different patterns of biological responses that they induce.

AB - Bryostatin 1 and phorbol-12-myristate-13-acetate (PMA) are both potent activators of protein kinase C (PKC), although in primary mouse keratinocytes bryostatin 1 does not induce differentiation and blocks PMA-induced differentiation. We report here that in primary mouse keratinocytes PMA caused translocation of PKC-ε to the Triton X-100-soluble fraction with an approximately 2-order of magnitude higher potency, compared with translocation of PKC-α and PKC-δ. The kinetics of translocation were fastest for PKC-ε, slower for PKC-α, and slowest for PKC-δ. At 5-20 min bryostatin 1 showed potency similar to that of PMA for translocating PKC-α, higher potency for translocating PKC-δ, and lower potency for translocating PKC-ε. At a later time (6 hr), bryostatin 1 was 1-2 orders magnitude more potent than PMA for causing loss of PKC-α, -δ, and -ε from the soluble fraction. Bryostatin 1 was 40-fold more potent than PMA for down-regulating PKC-α and showed a biphasic dose-response curve for down-regulating PKC-δ. Bryostatin 1 at 0.1-1 nM down-regulated PKC-δ to a similar extent as did PMA. Bryostatin 1 at 100 nM to 1 μM, on the other hand, failed to induce down-regulation, and these high (100 nM to 1 μM) doses of bryostatin 1 showed noncompetitive inhibition of PKC-δ down-regulation by 1 μM PMA after coapplication. This protected portion of PKC-δ retained kinase activity. The dose-response curve for bryostatin 1 protection of PKC-δ from down- regulation by PMA correlated with bryostatin 1 inhibition of the effects of PMA on cornified envelope formation (a marker of differentiation) and epidermal growth factor binding. Although PKC-ε was readily translocated by both PMA and bryostatin 1, the PKC-ε originally associated with the particulate fraction showed no down-regulation by either of these agents. We hypothesize that differential regulation of PKC isozymes by PMA and bryostatin 1 may contribute to the different patterns of biological responses that they induce.

UR - http://www.scopus.com/inward/record.url?scp=0028126624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028126624&partnerID=8YFLogxK

M3 - Article

C2 - 7969070

AN - SCOPUS:0028126624

VL - 46

SP - 840

EP - 850

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 5

ER -